| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―03 |
Adverse events related to drug-drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review |
Valeria Conti, Nicola Bertini, Rosaria Ricciardi, Berenice Stefanelli, Emanuela De Bellis, Carmine Sellitto, et al. (+5) Marco Cascella, Francesco Sabbatino, Graziamaria Corbi, Pasquale Pagliano, Amelia Filippelli |
| 2 |
[GO] |
2023―Nov―30 |
Drug-drug interactions between COVID-19 therapeutics and psychotropic medications |
Alessandro Cuomo, Giovanni Barillà, Gianluca Serafini, Andrea Aguglia, Andrea Amerio, Matteo Cattolico, et al. (+3) Pietro Carmellini, Alessandro Spiti, Andrea Fagiolini |
| 3 |
[GO] |
2023―Nov―07 |
Drug-drug interactions between COVID-19 drug therapies and antidepressants. |
Efstathia Davoutis, Chrysa Panou, Nikolina Stachika, Christina Dalla, Nikolaos Kokras |
| 4 |
[GO] |
2023―Nov―05 |
Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in Covid-19 patients: a narrative review |
Tsubasa Takizawa, Keiko Ihara, Shunsuke Uno, Seiya Ohtani, Narumi Watanabe, Noboru Imai, et al. (+4) Jin Nakahara, Satoko Hori, David Garcia-Azorin, Paolo Martelletti |
| 5 |
[GO] |
2023―Oct―06 |
Drug-drug interactions between COVID-19 therapeutics and antiretroviral treatment: the evidence to date |
Camden Ellis, Keita Inaba, Christine Van de Vuurst, Atheel Ghrayeb, Theodore James Cory |
| 6 |
[GO] |
2023―Jun―24 |
The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions |
Samuel Villemure, Shanna C Trenaman, Kerry B Goralski |
|
